TY - JOUR
T1 - An ultrasensitive paper-based SERS sensor for detection of nucleolin using silver-nanostars, plastic antibodies and natural antibodies
AU - Suleimenova, Akmaral
AU - Frasco, Manuela F.
AU - Sales, M. Goreti F.
N1 - info:eu-repo/grantAgreement/FCT//COVID%2FBD%2F152662%2F2022/PT#
info:eu-repo/grantAgreement/FCT//PD%2FBD%2F142776%2F2018/PT#
info:eu-repo/grantAgreement/EC/H2020/829040/EU#
Funding Information:
The authors acknowledge the financial support from the European Commission through the project MindGAP (FET-Open/H2020/GA829040) and the Fundação para a Ciência e a Tecnologia (FCT) for funding (grant references PB/BD/142776/2018 and COVID/BD/152662/2022, given to Akmaral Suleimenova)
Publisher Copyright:
© 2024 The Authors
PY - 2024/7/10
Y1 - 2024/7/10
N2 - A state-of-the-art, ultrasensitive, paper-based SERS sensor has been developed using silver nanostars (AgNSs) in combination with synthetic and natural antibodies. A key component of this innovative sensor is the plastic antibody, which was synthesized using molecularly imprinted polymer (MIP) technology. This ground-breaking combination of paper substrates/MIPs with AgNSs, which is similar to a sandwich immunoassay, is used for the first time with the aim of SERS detection and specifically targets nucleolin (NCL), a cancer biomarker. The sensor device was carefully fabricated by synthesizing a polyacrylamide-based MIP on cellulose paper (Whatman Grade 1 filter) by photopolymerization. The binding of NCL to the MIP was then confirmed by natural antibody binding using a sandwich assay for quantitative SERS analysis. To facilitate the detection of NCL, antibodies were pre-bound to AgNSs with a Raman tag so that the SERS signal could indicate the presence of NCL. The composition of the sensory layers/materials was meticulously optimized. The intensity of the Raman signal at ∼1078 cm−1 showed a linear trend that correlated with increasing concentrations of NCL, ranging from 0.1 to 1000 nmol L−1, with a limit of detection down to 0.068 nmol L−1 in human serum. The selectivity of the sensor was confirmed by testing its analytical response in the presence of cystatin C and lysozyme. The paper-based SERS detection system for NCL is characterized by its simplicity, sustainability, high sensitivity and stability and thus embodies essential properties for point-of-care applications. This approach is promising for expansion to other biomarkers in various fields, depending on the availability of synthetic and natural antibodies.
AB - A state-of-the-art, ultrasensitive, paper-based SERS sensor has been developed using silver nanostars (AgNSs) in combination with synthetic and natural antibodies. A key component of this innovative sensor is the plastic antibody, which was synthesized using molecularly imprinted polymer (MIP) technology. This ground-breaking combination of paper substrates/MIPs with AgNSs, which is similar to a sandwich immunoassay, is used for the first time with the aim of SERS detection and specifically targets nucleolin (NCL), a cancer biomarker. The sensor device was carefully fabricated by synthesizing a polyacrylamide-based MIP on cellulose paper (Whatman Grade 1 filter) by photopolymerization. The binding of NCL to the MIP was then confirmed by natural antibody binding using a sandwich assay for quantitative SERS analysis. To facilitate the detection of NCL, antibodies were pre-bound to AgNSs with a Raman tag so that the SERS signal could indicate the presence of NCL. The composition of the sensory layers/materials was meticulously optimized. The intensity of the Raman signal at ∼1078 cm−1 showed a linear trend that correlated with increasing concentrations of NCL, ranging from 0.1 to 1000 nmol L−1, with a limit of detection down to 0.068 nmol L−1 in human serum. The selectivity of the sensor was confirmed by testing its analytical response in the presence of cystatin C and lysozyme. The paper-based SERS detection system for NCL is characterized by its simplicity, sustainability, high sensitivity and stability and thus embodies essential properties for point-of-care applications. This approach is promising for expansion to other biomarkers in various fields, depending on the availability of synthetic and natural antibodies.
KW - Molecularly imprinted polymers
KW - Natural antibodies
KW - Nucleolin
KW - Sandwich assay
KW - SERS
KW - Silver nanostars
UR - http://www.scopus.com/inward/record.url?scp=85198524043&partnerID=8YFLogxK
U2 - 10.1016/j.talanta.2024.126543
DO - 10.1016/j.talanta.2024.126543
M3 - Article
C2 - 39018947
AN - SCOPUS:85198524043
SN - 0039-9140
VL - 279
JO - Talanta
JF - Talanta
M1 - 126543
ER -